The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis
Open accessAbstract
Background and aims: The incidence of irritable bowel syndrome (IBS) or functional bowel disorders (FBD) after bacillary dysentery (BD) has not been extensively evaluated, and little is known of the pathogenesis of post-infective (PI) IBS. Therefore, we investigated the incidence of IBS and FBD in a Chinese patient population who had recovered from BD. To further elucidate its pathogenesis, neuroimmunological changes, including interleukins (IL), mast cells, neuropeptides, and the relationship between mast cells and intestinal nerves, were investigated. Methods: A cohort study of 295 patients who had recovered from BD (shigella identified from stool in 71.4%) and 243 control subjects consisting of patient siblings or spouses who had not been infected with BD were included in the study. All subjects were followed up using questionnaires for 1–2 years to explore the incidence of FBD and IBS, as defined by the Rome II criteria. In 56 cases of IBS (PI and non-PI) from another source, the number of mast cells in biopsy specimens from the intestinal mucosa were stained with antitryptase antibody and counted under light microscopy. Also, the relationship of mast cells to neurone specific enolase (NSE), substance P (SP), 5-hydroxytryptamine (5-HT), or calcitonin gene related peptide positive nerve fibres was observed using double staining with alcian blue and neuropeptide antibodies. In 30 cases of IBS (PI-IBS, n = 15) taken at random from the 56 cases, expression of interleukin (IL)-1α, IL-1β, and IL-1 receptor antagonist (IL-1ra) mRNAs in intestinal mucosa were identified using reverse transcription-polymerase chain reaction. The above results were compared with 12 non-IBS controls. Results: In the BD infected cohort, the incidences of FBD and IBS were 22.4% and 8.1% (in total)–10.2% (among those in who shigella were identified) respectively, which were significantly higher (p<0.01) than the incidences of FBD (7.4%) and IBS (0.8%) in the control cohort. A longer duration of diarrhoea (⩾7 days) was associated with a higher risk of developing FBD (odds ratio 3.49 (95% confidence interval 1.71–7.13)). Expression of IL-1β mRNA in terminal ileum and rectosigmoid mucosa was significantly higher in PI-IBS patients (p<0.01). The number of mast cells in the terminal ileum mucosa in PI-IBS (11.19 (2.83)) and non-PI-IBS patients (10.78 (1.23)) was significantly increased compared with that (6.05 (0.51)) in control subjects (p<0.01). Also, in the terminal ileum and rectosigmoid mucosa of IBS patients, the density of NSE, SP, and 5-HT positively stained nerve fibres increased (p<0.05) and appeared in clusters, surrounding an increased number of mast cells (p<0.01 compared with controls). Conclusions: BD is a causative factor in PI-IBS. The immune and nervous system may both play important roles in the pathogenesis of PI-IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have demonstrated increased concentrations of activated mast cells in patients with IBS compared with controls (11, 13, 24, 46, 89, 94, 121, 187).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [187]
In the citing paper
“Notably, some studies demonstrated an increase in activated mast cells in biopsies from specific regions of the GI tract (i.e., cecum and terminal ileum) but not from other regions (e.g., ascending colon, descending colon, rectum) (89, 121, 187), whereas other studies have found activated mast cells in the descending colon (11, 13).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [187]
In the citing paper
“Levels of interleukin (IL)-1β mRNA may be increased in the small intestine, colon, and rectum of patients with PI-IBS compared with healthy controls (75, 187), supporting the hypothesis that low-grade inflammation is present in patients with PI-IBS.”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [187]
In the citing paper
“The importance of the interaction between the intestinal microbiota and immune system in IBS patients is demonstrated by a few studies in patients with PI-IBS, indicating activation of the GI immune system following the acute GI infection (57, 58, 75, 89, 94, 124, 168, 170, 187)”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies
Pritchard, J. K., & Rosenberg, N. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302449 · Cited by 1,198
Population stratification and spurious allelic association
Cardon, L. R., & Palmer, L. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12520-2 · Cited by 1,189
Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155
Hampe, J., Cuthbert, A. P., Croucher, P. J. P., Mirza, M. M., Mascheretti, S., Fisher, S. A., Frenzel, H., King, K., Hasselmeyer, A., Macpherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,090
Grölund, M., Lehtonen, O. ‐., Eerola, E., & Kero, P. O. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199901000-00007 · Cited by 873
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
Flagged first, then by citations
Research works printed but not linked: 8
- 2000, Chinese Med J, 113, 35
- Drossman D A. The functional GI disorders and the Rome II process. In: Drossman DA, et al, eds. The functional gastrointestinal disorders, 2nd edn. USA: Allen Press, 2000:1–30. · DOI
- 1999, Gut, 45, II43
- 1994, Gastroenterology, 106, A523
- 1998, Nature, 334, 698
- 10.1053/gast.2002.37071 · DOI
- 2000, News Physiol Sci, 15, 213
- 2002, Am J Physiol, 283, G612
Cited by
Sorted by citations
Items 301–387 of 387
Post-infectious irritable bowel syndrome: renaissance time?
Gaus, O. V., Livzan, M. A., & Александровна, Г. Д. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-35-23-28 · Cited by 3
Neuropathophysiology of the Irritable Bowel Syndrome
Wood, J. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00067-0 · Cited by 3
Etiology and pathophysiology of irritable bowel syndrome and chronic constipation
Camilleri, M. (2005) · Advanced studies in medicine · Cited by 3
Chronic symptoms persisting after travel-related infections
Bogacka, A., & Gajewski, M. (2018) · International Maritime Health · doi:10.5603/imh.2018.0033 · Cited by 4
“Among the cytokines, interleukin-1 beta is a crucial pro-inflammatory factor, and its concentration has been demonstrated to be increased in the terminal ileum and the recto-sigmoid colon of the PI-IBS patients [7] as well as in rectal biopsies of the patients who had PI-IBS [9].”
BackgroundDifferential expression of enteric neuroimmune‐network in invasive and acute watery diarrhoea
Sarker, P., Bhuiyan, T., Qadri, F., Alam, N. H., Wretlind, B., Bishop, A., Mathan, M. M., Agerberth, B., Andersson, J., & Raqib, R. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01375.x · Cited by 3
PATHOPHYSIOLOGICAL FACTORS OF IRRITABLE BOWEL SYNDROME, AND THE EFFECTS OF PROBIOTIC SUPPLEMENTATION
Kajander, K. (2008) · Työväentutkimus Vuosikirja · Cited by 3
Approach to the Patient with Diarrhea
Hecht, G. A., Gaspar, J. P., & Malespin, M. H. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch41 · Cited by 3
Ford, A. (2019) · Evidence-based Gastroenterology and Hepatology 4e · doi:10.1002/9781119211419.ch20 · Cited by 3
Eldesouki, M. H., Kloub, M., Elfert, K., Ibrahim, A., Grover, M., & Gayam, S. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70602 · Cited by 2
Alam, M., Abbas, K., Khan, M., Saini, R. S., & Faraz, M. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02317-8 · Cited by 2
Ochoa, T. J., & Cleary, T. G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50124-2 · Cited by 2
Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
Sheptulin, A. A., & Анатольевна, В.-Х. М. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2021-31-6-41-46 · Cited by 2
“лочке подвздошной кишки, и повышение экспрессии в ней интерлейкина-1β [12].”
Irritable bowel syndrome: pathophysiological and clinical issues
Ivashkin, V. T., & Poluektova, A. A. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Luo, Y., Wang, F., Qin, J., Feng, M., Lv, Y., Wang, Q., Liu, K., & Liu, C. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.03.002 · Cited by 2
“However, most of these classical models of colitis were developed by chemical stimulation on gut, while the natural pathogenic process of the post-infection IBSwas the bacterial infections in the gut [30], so we developed a model of intestinal infection induced by S.”
Awareness about Irritable Bowel Syndrome (IBS). A Survey Based Study
Naveed, S., & Mehak, R. (2014) · HAL · Cited by 2
Gastroenterology Disease and Lifestyle Medicine
FRIEDMAN, G. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-24687-1_30 · Cited by 2
Genetics, Mucosal Inflammation and the Environment in Post-Infectious Chronic Gut Syndromes
Walker, M. M., Keely, S., Scott, R. J., & Talley, N. J. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2016.14 · Cited by 2
Post-infectious irritable bowel syndrome
Plotnikova, E. Y. (2018) · Herald of Pancreatic Club · doi:10.33149/vkp.2018.02.09 · Cited by 2
Pathophysiology Underlying the Irritable Bowel Syndrome
Wood, J. D. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50044-1 · Cited by 2
Irritable Bowel Syndrome in Inflammatory Bowel Disease
Ryu, K.-H., & Huh, K. (2010) · Intestinal Research · doi:10.5217/ir.2010.8.2.95 · Cited by 2
Health Advice for International Travel
Keystone, J. S., Steffen, R. J., & Kozarsky, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00126-9 · Cited by 2
Pickett‐Blakely, O., & Lee, L. (2009) · CRC Press eBooks · doi:10.1201/9781420067637.ch13 · Cited by 2
Diarrhea‐Predominant Bowel Disorders Following Inflammation and Infection
Spiller, R. E. (2004) · doi:10.1002/9780470760307.ch15 · Cited by 2
Piche, T. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89359-6 · Cited by 2
Confirmation of an old adage: You find what you seek
Sherman, P. M., & Tarr, P. I. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.10.056 · Cited by 2
Videlock, E. J., & Chang, L. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch75 · Cited by 2
Abdominal pain models: mechanisms and therapies and experimental models
Lucarini, E., Mannelli, L. D. C., & Ghelardini, C. (2020) · doi:10.36118/pharmadvances.03.2020.04 · Cited by 1
Neurogastroenterology and motility around the world
Sharkey, K. A., Szurszewski, J., & Tack, J. F. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01579.x · Cited by 1
Norlin, A. (2020) · Linköping University medical dissertations · doi:10.3384/diss.diva-170320 · Cited by 1
Novel strategies and future landmarks in the treatment of irritable bowel syndrome
Róka, R., Gecse, K. B., & Wittmann, T. (2009) · Therapy · doi:10.2217/thy.09.22 · Cited by 1
Peripheral and central factors in the pathophysiology of irritable bowel syndrome
Posserud, I. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Giardiasis in Bergen. Outbreak and clinical consequences.
Wensaas, K. (2011) · NORA - Norwegian Open Research Archives · Cited by 1
Ford, A., Moayyedi, P., & Talley, N. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch21
What??s new in enteric infectious diseases at home and abroad
DuPont, H. L. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200512000-00003 · Cited by 1
Spence, M. (2005) · ResearchSpace (University of Auckland) · Cited by 1
Escherichia coli: Enteric and Extraintestinal Infections
Lorenz, B. D., & Donnenberg, M. S. (2014) · ASM Press eBooks · doi:10.1128/9781555815486.ch5
Neuromuscular and Mechanical Disorders of the Large Intestine
Domizio, P., & Martin, J. E. (2012) · Wiley eBooks · doi:10.1002/9781118399668.ch34
Irritable Bowel Syndrome and Microbial Pathogenesis
Fong, I. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1670-2_1
Matricon, J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Gut Inflammation in Irritable Bowel Syndrome
Gwee, K. (2013) · Wiley eBooks · doi:10.1002/9781118444689.ch9
Assessing the risk of irritable bowel syndrome one year post-acute gastroenteritis
Kowalcyk, B. B. (2011)
GI Immune Response in Functional GI Disorders
Tack, J. F., & Kindt, S. (2009) · Frontiers of gastrointestinal research · doi:10.1159/000258287
ROLE OF ANTIMICROBIAL PEPTIDES IN COMBATING SHIGELLOSIS AND IN ANTIBIOTIC-ASSOCIATED DIARRHEA
Sarker, P. (2012) · Figshare
Relationship between genetic polymorphism and irritable bowel syndrome pathogenesis
Qiu, M., & Liu, S. (2008) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v16.i17.1912
Die neuronale Mediation von Stress am Beispiel tierexperimenteller Modelle
Stengel, M. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12278
Comprendre le dialogue: l’interaction entre les micro-organismes et l’hôte
Fasano, A. (2009) · Annales Nestlé (Ed française) · doi:10.1159/000222311
TREATMENT OF IBS: ARE BUGS THE DRUGS TO USE?
Harris, L. A. (2005) · Evidence-Based Gastroenterology · doi:10.1097/01.ebg.0000173363.87989.99
Understanding the Dialogue: the Microbial–Host Interaction
Fasano, A. (2009) · Annales Nestlé (English ed ) · doi:10.1159/000187165
“Enteric Pathogens The distinguishing characteristics of bacteria (small size, concise deployment of genetic information, and the ability to survive in highly varied circumstances) contribute to their acclaimed virtuosic ability to adapt and learn fast in order to survive. To be a successful enteric pathogen, a bacteri…”
Neumatosis colónica y síndrome del intestino irritable, ¿un nexo de unión?
García-Escribano, O. R., Carro, P. S. G., Roldán, F. P., & Huidobro, M. L. L. (2005) · Medicina Clínica · doi:10.1157/13074745
Conocimiento del diálogo de interacción entre el microbio y el hospedador
Fasano, A. (2009) · Annales Nestlé (Ed española) · doi:10.1159/000225912
Post-infectious Irritable Bowel Syndrome in the Community: A Prospective Cohort Study
Ryu, H. S., & Choi, S. C. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.1.1
“험도는 연구자마다 차이가 있으며 동양인을 대상으로 한 연구 및 이번 연구에서는 관련이 없었다.(2,8) 고령의 환자에서 감염 후 과민성 장증후군의 발생률을 낮게 보고한 연구에서는 장염”
Enteric infections: immune interactions, emergence and persistence
Boedeker, E. C. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000194789.51714.26
Controlled trial of hypnotherapy as a treatment for irritable bowel syndrome.
Phillips-Moore, J. (2009) · The Sydney eScholarship Repository (The University of Sydney)
The Role of Neurotransmitters in IBS Pathophysiology: A Literature Review
Washburn, S. (2007) · Australian journal of medical herbalism
배양검사로 확진된 지역사회 세균성 장염 환자에서 과민성 장증후군의 발생률과 위험요인
고성준, Ho, L. D., Hyub, L. S., Soo, P. Y., 황진혁, 김진욱, 정숙향, Kim, N., Im, J. P., Kim, J., et al. (2012)
PAR-2-Mediated Relaxation of Rectum is Impaired Following Bacillary Dysentery in Rat
Luo, Y., Wang, Q., & Liu, C. (2016) · International Journal of Clinical Pharmacology & Toxicology · doi:10.19070/2167-910x-si02001
“Because approximately 1/10 of IBS cases describe a post infectious onset and bacillary dysentery is a causative factor in PI-IBS [16, 17], so it’s necessary to investigate the alteration of rectum motility following SF-infection.”
Background14 Nutritional Management of Upper Gastrointestinal Disorders
Okeke, F. C., & Roland, B. C. (2017) · CRC Press eBooks · doi:10.1201/9781315100913-15
Sinagra, E., Rossi, F., Raimondo, D., Pietra, C., Pisciotto, P., Pompei, G., Tomasello, G., Cappello, F., Morreale, G. C., Amvrosiadis, G., et al. (2016)
Guilarte, M. (2014) · TDX (Tesis Doctorals en Xarxa)
Postinfectious Chronic Health Consequences of Acute Enteric Infections
Riddle, M. S., Kowalcyk, B. B., & Porter, C. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.03010-9
논평 : 지역사회에서의 감염 후 과민성 장증후군: 전향적 코호트 연구
류한승, & 최석채 (2012)
Jardí, F., & Vergara, P. (2011) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Epigenetics of Chronic Visceral Nociception
Zhou, Q., & Verne, G. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814070-3.00010-7
Infections Associated With Irritable Bowel Syndrome
Gurunathan, S. V., & Grover, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00007-6
Zhang, Y., Zhang, L., Li, S., Wu, X., Bi, Y., Hu, X., Chen, Y., & Yuan, Y. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i16.782
Rees, J. R. (2014) · ASM Press eBooks · doi:10.1128/9781555815486.ch4
Chey, W. Y. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727191505.793547346
State-of-the Art Lecture: Irritable bowel syndrome: the new inflammatory bowel disease?
Spiller, R. E. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5702-1_31
Nutritional Management of Upper Gastrointestinal Disorders
Okeke, F. C., & Roland, B. C. (2015) · CRC Press eBooks · doi:10.1201/b18833-15
Post-infectious irritable bowel syndrome: role of inflammation and gut flora
Spiller, R. E. (2007) · Springer eBooks · doi:10.1007/1-4020-4144-6_13
Epidemiology of Travelers' Diarrhea
Sanders, J. W., Riddle, M. S., & Taylor, D. N. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-1076-8.00018-1
5HT3 Antagonists a Newer Concept in Treatment of IBS-D in Females: A Review Article
Behera, R. (2022) · International Journal of Experimental and Clinical Research · doi:10.29011/2688-9536.100140
Ait-Belgnaoui, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Mucosal Inflammation and Visceral Hypersensitivity in Irritable Bowel Syndrome
Komori, K., Ihara, E., & Akiho, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-8410-3_6
Flynn, T. G., & Kosek, M. N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00109-6
Irritable bowel syndrome after acute intestinal infection: Aspects of therapy on a clinical example
Pakhomova, I. G. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-197
Zhang, D., Chen, C., Xie, Y., Zeng, F., Chen, S., Chen, R., Zhang, X., Huang, S., Li, D., & Bai, F. (2023) · Figshare · doi:10.6084/m9.figshare.23558048
Zhang, D., Chen, C., Xie, Y., Zeng, F., Chen, S., Chen, R., Zhang, X., Huang, S., Li, D., & Bai, F. (2023) · Figshare · doi:10.6084/m9.figshare.23558051
Dyukova, G. M., Makarova, A. A., Indeykina, L. K., Александрович, Д. Д., & Parfenov, A. I. (2026) · Medical alphabet · doi:10.33667/2078-5631-2026-2-7-12
Intestino irritable: una enfermedad orgánica en 2026
Díaz, J. A. U., Fernández, H. M., Ordoñez, J. S. F., Cheng, H. G. C., Espinoza‐Ríos, J., Parra, L. O., & Regino, W. O. (2026) · Revista de Gastroenterología del Perú · doi:10.47892/rgp.2026.462.2262
Low-Dose Glyphosate Exposure Alters the Enteric Tachykinin System in the Porcine Small Intestine
Walczak-Mośny, Z., Chmielewska‐Krzesińska, M., Jana, B., & Palus, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198598
“…diseases such as inflammatory bowel disease (IBD), DSS-induced models of intestinal inflammation, and inflammatory processes of infectious aetiology, increased expression of substance P and neurokinin receptors associated with activation of the neuroimmune axis has been demonstrated [28,33–35].”
Peris, M. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Wang, L.-H., Fang, X.-C., & Pan, G.-Z.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Pan, G-Z
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-07-09
- Volume
- 53
- Issue
- 8
- Pages
- 1096-1101
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC1774156
- OpenAlex
- W2158018898
- Cited by
- 387
- References
- 51
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 3 · 2023: 8 · 2022: 3 · 2021: 9 · 2020: 10 · 2019: 17 · 2018: 17 · 2017: 18 · 2016: 19 · 2015: 19 · 2014: 31 · 2013: 18 · 2012: 23
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Gut (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- shigellosis, irritable bowel syndrome, functional bowel disorders, Shigella, mast cells, neuroimmunology, substance P, calcitonin gene-related peptide, serotonin, interleukin-1, interleukin-1 receptor antagonist, intestinal nerves, pathogenesis, diarrhea duration
- MeSH terms
- Adult, Colonic Diseases, Functional, Diarrhea, Dysentery, Bacillary, Female, Follow-Up Studies, Humans, Interleukin-1, Intestinal Mucosa, Male, Mast Cells, Nerve Fibers, Phosphopyruvate Hydratase, Risk Factors, Serotonin, Substance P, Calcitonin Gene-Related Peptide, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
